share

Methyl 7-Bromo-3-Oxo-3,4-Dihydroquinoxaline-2-Carboxylate CAS NO 221167-40-4


Unit Price:

CAS No.:221167-40-4

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Methyl 7-Bromo-3-Oxo-3,4-Dihydroquinoxaline-2-Carboxylate is a high-purity, advanced pharmaceutical intermediate characterized by its brominated quinoxaline core structure. This compound is a critical building block in modern organic synthesis, enabling the development of novel active pharmaceutical ingredients (APIs) with targeted therapeutic effects. It is primarily utilized by research institutions and manufacturers in the pharmaceutical and agrochemical sectors for the synthesis of complex heterocyclic molecules.

Application

  • Pharmaceutical Intermediate: A key precursor in the synthesis of novel drug candidates, particularly those targeting central nervous system (CNS) disorders, oncology, and infectious diseases.
  • Agrochemical Research: Serves as a building block for developing new herbicides, fungicides, and insecticides with specific modes of action.
  • Material Science: Used in the research and development of organic electronic materials, such as organic light-emitting diodes (OLEDs) and semiconductors, due to its conjugated quinoxaline system.
  • Chemical Biology: Employed as a molecular probe or scaffold in medicinal chemistry for structure-activity relationship (SAR) studies and hit-to-lead optimization.
  • Academic & Contract Research: Essential for synthetic organic chemistry research in universities and contract research organizations (CROs) exploring new heterocyclic methodologies.

Basic Information

Product Name Methyl 7-Bromo-3-Oxo-3,4-Dihydroquinoxaline-2-Carboxylate
CAS No. 221167-40-4
Molecular Formula C10H7BrN2O3
Molecular Weight 283.08 g/mol
Synonyms 7-Bromo-3-oxo-3,4-dihydroquinoxaline-2-carboxylic acid methyl ester; Methyl 7-bromo-3-oxo-1,4-dihydroquinoxaline-2-carboxylate; 2-Methoxycarbonyl-7-bromo-3,4-dihydro-3-oxoquinoxaline; 7-Bromo-2-methoxycarbonyl-3,4-dihydro-3-oxoquinoxaline; 7-Bromo-3-oxo-3,4-dihydro-2-quinoxalinecarboxylic Acid Methyl Ester; MBODQC; 221167-40-4
EINECS Contact for details

Quality Control

Our Methyl 7-Bromo-3-Oxo-3,4-Dihydroquinoxaline-2-Carboxylate is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC, NMR, and mass spectrometry, to ensure identity, purity, and consistency. We provide comprehensive Certificates of Analysis (COA) with each shipment, detailing all critical quality attributes. Our production adheres to cGMP guidelines where applicable, ensuring reliability for your most demanding research and development projects.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). The compound is light-sensitive and should be handled under appropriate conditions to prevent degradation. Keep away from heat, sparks, and open flame.

Specification

Item Specification
Appearance White to off-white crystalline powder
Identification (IR) Conforms to structure
Identification (HPLC) Conforms to reference standard
Purity (HPLC) ≥ 98.0%
Loss on Drying ≤ 0.5%
Residue on Ignition ≤ 0.1%
Heavy Metals ≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

why choose us

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.